Polyphor In Peril After Breast Cancer Drug Failure

Shares Crash On Balixafortide Setback

 
• By Kevin Grogan
Swiss wallet
Money is tight at troubled Swiss biotech Polyphor • Source: Alamy

More from Anticancer

More from Therapeutic Category